Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

The session focused on the evolution of stroke care, particularly ischemic strokes, which make up 87% of all strokes. It ...

During medical emergencies, when decisions must be made quickly, knowing how blood thinners are affecting a person’s ability ...

From cancer immunotherapy to diabetes and weight loss breakthroughs, 2025’s top-selling drugs highlight how pharmaceutical ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback. At ...

Bristol-Myers Squibb's Eliquis (apixaban) for prevention and treatment of blood clots – down 56% to $231.00; Novartis' Entresto (valsartan/sacubitril) for heart failure – down 53% to $295.00; and ...